摘要
目的:利用基因工程的方法制备甲状腺钠/碘同向转运体(hNIS)cDNA,为今后的转基因治疗奠定物质基础。方法:采用TRIzol一步法,从甲状腺组织中提取总RNA,再应用RT-PCR扩增出hNIS基因全长,然后采用TOPO克隆技术构建重组表达质粒pcDNA3.1D/FLhNIS,并进行酶切和测序鉴定。结果:成功制备了hNIScDNA并构建了其重组表达质粒。结论:为最终实现131I治疗不摄碘的肿瘤提供了分子生物学基础。
Objective: To provide an objective evidence for transferring gene radioiodine therapy in nonthyroid tumor, build human sodium/iodide symporter(hNIS)cDNA by gene engineering. Methods:Total RNA was isolated from the thyroid tissue sample of Graves disease patient by TRIzol reagent, the hNIS gene was amplified by RT-PCR, the target gene were inserted into vector pcDNA3.1/D-V5-His to construct the recombinant expressive plasmid pcDNA3.1D/FLhNIS by TOPO clone methods, then restrictive enzyme digested and sequenced. Results: Successful building hNIS cDNA and its expressive plasmid. Conclusion: This method provides an objective molecular biologic evidence for radioiodine therapy in nonthyroid tumor.
出处
《天津医科大学学报》
2007年第3期318-322,326,共6页
Journal of Tianjin Medical University
基金
天津市卫生局科技基金资助项目(2005KY47)